Pralidoxime: Difference between revisions
(→Common) |
|||
| Line 36: | Line 36: | ||
===Common=== | ===Common=== | ||
*Tachycardia | |||
*Hypertension | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 22:50, 13 March 2021
General
- Also known as 2-PAM
- Type: Antidote
- Dosage Forms:
- Common Trade Names: Protopam
Adult Dosing
Organophosphate toxicity
- 1-2gm IV over 5-10min
- Continuous infusion of 500mg/hr if no initial response
Pediatric Dosing
Organophosphate toxicity
- 20-40mg/kg (up to 1gm) IV over 5-10min
- 5-10mg/kg/hr if no initial response
Special Populations
- Pregnancy Rating: C
- Lactation risk: Unknown
- Renal Dosing
- Adult - no requirements from manufacturer, but given that it is excreted in the urine dosage reduction is recommended.
- Pediatric
- Hepatic Dosing
- Adult - no adjustments recommended by manufacturer.
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Tachycardia
- Hypertension
- Laryngospasm
- Hepatitis
Common
- Tachycardia
- Hypertension
Pharmacology
- Half-life: Apparent: 74 to 77 minutes, IM/IV exposure: 3 to 4 hours
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action: Displaces an organophosphate from acetylcholinesterase (if given early before irreversible enzyme binding occurs, aka "aging")
